Text Search: Search by:

Refine your search with filters

Year:

Category:

All

Congress Abstracts

Tools & Skills

Publications

Congress Presentations

Videos & Podcasts

Quicksearch

DOP58: IDeaL – a multi-center prospective Infliximab Dose to Level pharmacokinetic study during induction in pediatric Crohn’s diseaseECCO'19 Copenhagen

Year: 2019

Authors: Geraldine H. Huynh

Anti TNF drug levels, Calprotectin and other faecal biomarkers, CRP and other serum biomarkers, Therapeutic drug monitoring, Infliximab, Pharmacokinetics, Paediatric, Investigator-led

Files: 1

DOP59: Proactive Infliximab Drug Monitoring Is Superior To Conventional Management In Inflammatory Bowel DiseaseECCO'19 Copenhagen

Year: 2019

Authors: Samuel Raimundo Fernandes

Anti TNF drug levels, Mucosal healing, Therapeutic drug monitoring, Infliximab

Files: 1

DOP61: A nationwide cohort study of colectomy rates for ulcerative colitis during the introduction of biologic therapyECCO'19 Copenhagen

Year: 2019

Authors: Jonathan Segal

Epidemiology, Natural history, Ulcerative colitis, Colectomy, Anti-TNF agents, Infliximab, Acute Severe Colitis

Files: 1

DOP62: A Novel Formulation of CT-P13 (Infliximab Biosimilar) for Subcutaneous Administration: 1-Year Result from a Phase I Open-label Randomised Controlled Trial in Patients with Active Crohn’s DiseaseECCO'19 Copenhagen

Year: 2019

Authors: Walter Reinisch

Outcome measures, Mucosal healing, Infliximab, Pharmacokinetics

Files: 1

DOP63: Adalimumab for patients with Crohn’s disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort studyECCO'19 Copenhagen

Year: 2019

Authors: Guillaume Pineton de Chambrun

Natural history, Crohn’s disease, Montreal Classification, MRI, Adalimumab, Anti-TNF agents, Penetrating disease, Abscess, Outcome measures

Files: 1

DOP64: Minimal additional benefits in adding fecal hemoglobin to fecal calprotectin in predicting endoscopic disease activity in patients with inflammatory bowel diseaseECCO'19 Copenhagen

Year: 2019

Authors: Lung-Yi Mak

Crohn’s disease, Ulcerative colitis, Calprotectin and other faecal biomarkers, CRP and other serum biomarkers

Files: 1

DOP65: The association of fecal calprotectin level and combined mucosal and transmural healing in patients with Crohn's diseaseECCO'19 Copenhagen

Year: 2019

Authors: Soomin Noh

Calprotectin and other faecal biomarkers, Crohn’s disease

Files: 1

DOP66: Surveillance colonoscopies in Ulcerative Colitis: Does it make a difference?ECCO'19 Copenhagen

Year: 2019

Authors: Narula Neeraj

Colonoscopic surveillance, colonoscopy, Colonoscopy, UC colorectal cancer surveillance, IBD-associated cancer, Colorectal cancer

Files: 1

DOP67: Magnification endoscopy with optical chromoendoscopy for in vivo assessment of histologic inflammation in patients with inflammatory bowel diseaseECCO'19 Copenhagen

Year: 2019

Authors: Entcho Klenske

Crohn’s disease, Ulcerative colitis, colonoscopy, Mucosal healing, Chromoendoscopy, Colonoscopy, Mucosal healing, Disease activity indices, Mucosal healing

Files: 1

DOP70: An integrated multi-omics biomarker predicting endoscopic response in ustekinumab treated patients with Crohn's diseaseECCO'19 Copenhagen

Year: 2019

Authors: Bram Verstockt

Treat to target, Ustekinumab

Files: 1

DOP71: Effects of ustekinumab induction therapy on endoscopic and histologic healing in the UNIFI phase 3 study in ulcerative colitisECCO'19 Copenhagen

Year: 2019

Authors: Katherine Li

Histology, Ulcerative colitis, Mucosal healing, Ustekinumab, Mucosal healing, Mucosal healing

Files: 1

DOP72: Increased risk of advanced neoplasia in inflammatory bowel disease patients with recurrent low-grade dysplasiaECCO'19 Copenhagen

Year: 2019

Authors: Michiel de Jong

Crohn’s disease, Ulcerative colitis, Dysplasia, Dysplasia, Colorectal cancer

Files: 1

DOP73: Treatment of perianal fistulas in Crohn’s disease, seton versus anti-TNF versus surgical closure following anti-TNF (PISA): a randomised controlled trialECCO'19 Copenhagen

Year: 2019

Authors: Karin Wasmann

Disease activity Indices, Patient reported outcomes, Quality of life (IBDQ), MDT, 5-ASA, Adalimumab, Anti-TNF agents, Infliximab, Thiopurines (AZA / MP), Perianal disease, Perianal fistulae, Abscess, Perianal disease, Adherence to therapy, Sexuality, Real world data, Patient reported outcomes

Files: 1

DOP74: Efficacy of ustekinumab in perianal Crohn’s disease: the BioLAP multicenter observational study.ECCO'19 Copenhagen

Year: 2019

Authors: Constance Biron

Ustekinumab, Perianal fistulae, Perianal disease

Files: 1

DOP76: Prevalence and health-care costs of perianal fistulas in Crohn’s disease in a nationwide cohortECCO'19 Copenhagen

Year: 2019

Authors: Niels Qvist

Epidemiology, Crohn’s disease, Health economic analysis, Perianal disease

Files: 1

DOP78: Efficacy of vedolizumab in perianal Crohn’s disease: the BioLAP multicenter observational studyECCO'19 Copenhagen

Year: 2019

Authors: Constance Biron

Vedolizumab, Perianal disease, Perianal disease

Files: 1

DOP79: Effect of vedolizumab on surgical rates in IBD: Post hoc analysis from the GEMINI trialsECCO'19 Copenhagen

Year: 2019

Authors: Trevor Lissoos

Vedolizumab, Outcome measures

Files: 1

DOP80: Oral curcumin is not more effective than placebo to prevent endoscopic postoperative recurrence in patients with Crohn's disease treated with concomitant thiopurines: the POPCUR trial.ECCO'19 Copenhagen

Year: 2019

Authors: Anthony Buisson

Complementary therapies, Thiopurines (AZA / MP), Investigator-led

Files: 1

DOP81: Utility of a Simple Blood Test for Mucosal Healing Monitoring is Accurate in Post-Operative Crohn’s DiseaseECCO'19 Copenhagen

Year: 2019

Authors: Amy L Hamilton

Crohn’s disease, Colonoscopic surveillance, CRP and other serum biomarkers, Mucosal healing, Post operative medical management, Post-operative IBD, Mucosal healing

Files: 1

DOP82: Direct and indirect costs of inflammatory bowel disease in the biological era; ten years of follow up in a Danish population-based inception cohortECCO'19 Copenhagen

Year: 2019

Authors: Bobby Lo

Epidemiology, Natural history, Crohn’s disease, Ulcerative colitis, Health economic analysis

Files: 1